Financial News

Amgen Shares Touch New Record

Amgen Shares Touch New Record

Amgen (AMGN) shares rose to a new record on Monday as the company and Allergan (AGN) said a phase 3 study support ABP 980 as a Herceptin (trastuzumab) biosimilar in patients with human epidermal growth factor receptor 2-positive early breast cancer compared with the originator product. AMGN was up 2% at $183.85 recently, trading in a new 52-week range between […]